Are we ready for routine clinical genomics in cardiovascular disease?

The use of genetic testing in healthcare is becoming increasingly relevant, especially in the field of cardiovascular disease. While current cardiology guidelines include recommendations for the incorporation of genetic testing, its adoption into clinical practice remains limited.

In this webinar, David Lanfear, advanced heart failure and transplant cardiologist, and Denise Perry, genetic counselor, will discuss current and future applications of genetics in healthcare. They will share practical considerations for integrating genetic testing into clinical and laboratory workflows, focusing on test development and initial findings from the CardioSeq clinical trial, which created a novel testing platform and assessed the clinical impact of a pragmatic clinical whole-genome sequencing test.

Learning objectives

• Understand current clinical guidelines for genetic testing in cardiology
• Identify common barriers for the implementation of real-world adoption of genetic testing in cardiology
• Learn about a clinical whole-genome sequencing test developed and deployed by Illumina Laboratory Services, designed to aid in the molecular diagnosis and risk assessment for cardiovascular disease
• Review the preliminary findings of the CardioSeq clinical trial

Speakers

David E. Lanfear, MD, MS, FAHA, FACC, FHFSA
Chief Scientific Officer, Vice President of Research
Henry Ford Health, Professor of Medicine, WSU-SoM, MSU-CHM

Denise L. Perry, MS, CGC
Sr Director, Medical Genomics Lab Services, Illumina Lab Services
Illumina